Concepedia

Publication | Open Access

Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors

DOIFull Paper Access

23

Citations

39

References

2018

Year

Naris Nilubol, Ziqiang Yuan, Giulio F. Paciotti, Lawrence Tamarkin, C. Rodríguez Sánchez, Kelli Gaskins, Esther M. Freedman, Shugeng Cao, Jielu Zhao, David G. I. Kingston,
JNCI Journal of the National Cancer Institute

Abstract

CYT-21625 is effective in mice with PNETs and metastatic human thyroid cancer with no toxicities. Thus, CYT-21625 should be studied in patients with advanced PNETs and thyroid cancer.

References

YearCitations

Page 1